Anti-Ageing
What is anti ageing medicine?
The ageing process starts at age 30. There are several theories of the ageing process but all of them amount to processes that affect the system in general and our cells fundamentally which include a decline in energy production and the structural change of proteins. An effective anti-aging therapy brings together agents that counteract the reduction in cell energy production and protein damage. More importantly this can be achieved by natural substances without the need for toxic pharmaceuticals. This also allows for better long term and safe use of these agents.
There is no direct method of measuring aging at a cellular level, however there are a few tests that indirectly give a clue as to how well or not that we are aging. These involve a couple of blood tests together with measuring HRV (heart rate variability). Age Defi is a 'Chiron' Anti-Aging formula which has been tested and found to improve stress resilience and decrease vulnerability to the aging process, improving well being and having an anti-aging effect.
Age Defi is a natural nutritional supplement that has demonstrated reduced aging and enhanced well-being by improving cell health in general. This has also provided a natural wrinkle & cellulite solutions without needles and without surgery.
Breast Health Maintenance
Breast Health Management Approximately every 3 minutes worldwide a woman is diagnosed with breast cancer and approximately every 12 minutes a woman dies of it. Breast cancer is the second most common cancer in women and is the commonest cause of cancer related death in women aged 18-54. About 1.7 million women suffer worldwide. Approximately 1 woman in 8 will receive a diagnosis of breast cancer during her lifetime and 1 in 30 will die of the disease. Sadly, in women aged 45-50 it is the most common cause of death.
In the UK some 40,000 women are diagnosed each year. It is the most common form of cancer in females in the UK, giving rise to 12,800 deaths in 2000. Of 1.2 million British women aged over 45 screened with mammography in 2000/2001, 8,345 were found to have cancer and of these 6,588 were characterized as invasive.
The risk of surviving is still the same as it was 50 years ago. There is now evidence from recent reviews that mammography screening has not made any significant impact on death rates from breast cancer (especially if DCIS statistics are taken into account).
It is also apparent that 90% of breast cancers are first spotted by women themselves or by their partners.
The key to surviving breast cancer is early detection and treatment which is why routine monthly breast self examination is repeatedly recommended to all women from age 20 but the reality is that a cancer is likely to have been growing 10 years before it is clinically palpable. There is no clinical or scientific evidence to suggest that self or clinical breast examination makes any significant difference to outcome. As women age their risk of breast cancer increases and 77% of women with breast cancer are over age 50. Whilst breast cancer is less common in the younger age group, they still represent about a quarter of all patients and it is significant that they tend to have more aggressive cancers.
| By age 30 | 1 out of 2,212 | ||
|---|---|---|---|
| By age 40 | 1 out of 235 | ||
| By age 50 | 1 out of 54 | ||
| By age 60 | 1 out of 23 | ||
| By age 70 | 1 out of 10 | ||
| By age 80 | 1 out of 8s |
Up till now recommendations (although these differ between organizations) are annual screening mammograms for all women from age 40 in conjunction with monthly self breast examinations and yearly clinical breast examination. In women aged 20 to 39 monthly self-breast examination and 3 yearly clinical breast exams are often recommended.
Menopause Support
Magnopulse ladycare from The Chiron Clinic is an easy to use device that is attached to underwear next to your skin and it attaches magnetically. It applies a static magnetic field into the pelvic area. which has been found to improve many symptoms of the menopause including fatigue, difficulty sleeping,dry skin, bloating and weight loss.
Breast Thermal Imaging
Approximately every 3 minutes worldwide a woman is diagnosed with breast cancer and approximately every 12 minutes a woman dies of it. Sadly, in women aged 45-50 it is the most common cause of death. In the UK some 40,000 women are diagnosed each year. The key to surviving breast cancer is early detection. Medical infared Scanning provides breast screening and monitoring without radiation:
How does it work?
Breast medical infrared scanning uses state of the art technology which scans the body using a thermal imaging camera to produce an image or "thermal scan". This is based on findings that breast tumours have abnormal blood vessel patterns that give off more heat than the surrounding tissue. This blood vessel growth that accompanies tumour formation is termed neovascularization. Neovascularization is the earliest sign of a rapidly growing tumour and can be determined with infrared technology.
A thermal scan analyses the heat that is given off by the breast and allows for immediate display onto a computer monitor. The images obtained provide an indirect measurement of the metabolic activity of breast tissue. In other words, cancer is identified on a thermal scan as focal 'hot spots' and abnormal blood vessel patterns. Breast medical infrared scanning is as safe as getting your picture taken. There is no radiation exposure or anything invasive about the test: in fact there is no contact at all with the body.
Can a thermal imaging scan be used instead of a mammogram?
Thermal Imaging is NOT an alternative to mammography. Anyone making this claim is seriously misinformed. Thermal Imaging does not medically, scientifically, or legally replace mammography. It has an entirely different place in the monitoring of a woman's breast health. There is a distinct advantage of infrared thermal imaging in younger pre-menopausal women who are often difficult to diagnose accurately because of the density of the breast tissue. Adding thermographic screening in a physiologic detection category to the current base of knowledge will assist in catching some cancers and other breast diseases much earlier, providing for earlier intervention and hopefully a better clinical outcome.
Thermal imaging before and after breast surgery for early detection
Thermal scans' performed before and after a surgery or other treatment can help evaluate the success of the procedure by monitoring the metabolic and vascular changes of the cancer site. Additionally, once a woman develops breast cancer she is at a higher risk of developing it again. thermal scans' offer early detection of reoccurrence.
Current recommendations (although these differ between organisations) are to have annual screening mammograms for all women from age 40 in conjunction with monthly self breast examinations and yearly clinical breast examination. In women aged 20 to 39 monthly self-breast examination and 3 yearly clinical breast exams are often recommended.
Procedure information is copyright Department of Health (http://www.dh.gov.uk. Reproduced under the terms of the Click-Use Licence.
